AKT1 and inflammatory bowel disease: KEGG pathway enrichment analysis further supported that metabolic pathways including the TCA cycle, glucagon signaling, PI3K-Akt, and mTOR signaling were perturbed in IBD, suggesting potential disease-specific metabolic reprogramming (Figures 3B,C).